Neuromodulation for treatment of retinal, choroidal and optic nerve disorders and/or dysregulated reduced ocular blood flow (OBF)

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 12059385
APP PUB NO 20210022948A1
SERIAL NO

16932772

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A method and/or device for treatment of dysregulated reduced blood (e.g., reduced ocular blood flow) and, more particularly, but not exclusively, to methods and/or devices for treatment retinal, choroidal and optic nerve disorders. The treatment includes application of an effective amount of ONS ophthalmic nerve stimulation alone and/or in combination with peri-ocular administration of substance Neuropeptides/Platelet Rich Plasma (N/PRP) and/or ascorbic acid as a sympatholytic agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MUSALLAM ISMAIL MOHAMMED YOUSIFJERUSALEM

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Musallam, Ismail Mohammed Yousif Jerusalem, IL 4 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 13, 2028
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 13, 2032
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 13, 2036
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00